Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 398 is a member of the Kruppel family of C2H2-type zinc-finger transcription factors, primarily functioning as a transcriptional activator in human cells[1]. It acts in concert with SMAD3 and the histone acetyltransferase EP300 to regulate gene expression, particularly at active promoters and enhancers[2]. In human pluripotent stem cells (hPSCs), ZNF398 is involved in maintaining pluripotency and epithelial characteristics and repressing genes associated with differentiation, such as those involved in neuroectodermal and mesenchymal transitions[2]. Two main isoforms are described: p71 (predominant in hPSCs, involved in pluripotency regulation) and p52 (promotes proliferation by ubiquitination of p53 in cancer cells)[2]. This protein is intracellular and lacks any known association with small molecule drug targeting or approved therapeutics[1][2][3]. Diseases associated with ZNF398 include certain cataracts and Gand syndrome, as well as roles linked to cancer biology[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 398 (ZNF398).